BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Centro Nacional de Investigaciones Oncológicas (9)
2021
-
Measurable residual disease in elderly acute myeloid leukemia: Results from the PETHEMA-FLUGAZA phase 3 clinical trial
Blood Advances, Vol. 5, Núm. 3, pp. 760-770
-
The mutational landscape of acute myeloid leukaemia predicts responses and outcomes in elderly patients from the pethema-flugaza phase 3 clinical trial
Cancers, Vol. 13, Núm. 10
2019
-
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
Leukemia, Vol. 33, Núm. 5, pp. 1256-1267
2015
-
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Nature, Vol. 526, Núm. 7574, pp. 519-524
2012
-
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Nature Genetics, Vol. 44, Núm. 1, pp. 47-52
2011
-
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Nature, Vol. 475, Núm. 7354, pp. 101-105
2010
-
International network of cancer genome projects
Nature, Vol. 464, Núm. 7291, pp. 993-998
2009
-
Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas
Cancer, Vol. 115, Núm. 16, pp. 3728-3737
2003
-
Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations
Blood, Vol. 101, Núm. 10, pp. 4042-4046